Pilot study to validate a computer-based clinical decision support system for dyslipidemia treatment (HTE-DLP).

[1]  Miriam C.J.M. Sturkenboom,et al.  Electronic Alerts Versus On-Demand Decision Support to Improve Dyslipidemia Treatment: A Cluster Randomized Controlled Trial , 2008, Circulation.

[2]  Harel Gilutz,et al.  Original Articles , 2003 .

[3]  D. Fernández-Bergés,et al.  [Risk factor treatment and control in relation to coronary disease risk in the Spanish population of the DARIOS Study]. , 2011, Revista espanola de cardiologia.

[4]  H. Young,et al.  Effect of Electronic Prescription on Attainment of Cholesterol Goals , 2011, Clinical cardiology.

[5]  R. Elosua,et al.  Risk Factor Treatment and Control in Relation to Coronary Disease Risk in the Spanish Population of the DARIOS Study , 2011 .

[6]  A. Bertoni,et al.  Implementing a palm pilot intervention for primary care providers: lessons learned. , 2009, Contemporary clinical trials.

[7]  N. Plana,et al.  [Objective-oriented planification in the treatment of hypercholesterolemia]. , 2005, Medicina clinica.

[8]  G. Nocea,et al.  Current lipid management and low cholesterol goal attainment in common daily practice in Spain , 2012, PharmacoEconomics.

[9]  R Brian Haynes,et al.  Computerized clinical decision support systems for chronic disease management: A decision-maker-researcher partnership systematic review , 2011, Implementation science : IS.

[10]  G. Barnett,et al.  Randomized controlled trial of an informatics-based intervention to increase statin prescription for secondary prevention of coronary disease , 2007, Journal of General Internal Medicine.

[11]  J. Marrugat,et al.  Epidemiologia del sindrome coronario agudo en Espana: estimacion del numero de casos y la tendencia de 2005 a 2049 , 2013 .

[12]  Haiying Chen,et al.  Impact of a multifaceted intervention on cholesterol management in primary care practices: guideline adherence for heart health randomized trial. , 2009, Archives of internal medicine.

[13]  Jerzy Bełtowski,et al.  Adverse effects of statins - mechanisms and consequences. , 2009, Current drug safety.

[14]  Yu-Chuan Li,et al.  A guideline-based decision support for pharmacological treatment can improve the quality of hyperlipidemia management , 2010, Comput. Methods Programs Biomed..

[15]  N J Wald,et al.  Quantifying effect of statins on low density lipoprotein cholesterol, ischaemic heart disease, and stroke: systematic review and meta-analysis , 2003, BMJ : British Medical Journal.

[16]  J C Wyatt,et al.  Computerised decision support systems in order communication for diagnostic, screening or monitoring test ordering: systematic reviews of the effects and cost-effectiveness of systems. , 2010, Health technology assessment.

[17]  W. Tan,et al.  Evaluating user satisfaction with an electronic prescription system in a primary care group. , 2009, Annals of the Academy of Medicine, Singapore.

[18]  N. Plana,et al.  PlanificaciÓn del tratamiento de la hipercolesterolemia orientada a la obtenciÓn de objetivos , 2005 .

[19]  R. Elosua,et al.  Focus on: Epidemiology of Cardiovascular Disease in Spain Over the Past 20 Years (I) Epidemiology of Acute Coronary Syndromes in Spain: Estimation of the Number of Cases and Trends From 2005 to 2049 , 2017 .

[20]  P. Kolh,et al.  ESC/EAS Guidelines for the management of dyslipidaemias: the Task Force for the management of dyslipidaemias of the European Society of Cardiology (ESC) and the European Atherosclerosis Society (EAS). , 2011, European heart journal.

[21]  J. Paolini,et al.  Efficacy and safety of extended‐release niacin/laropiprant plus statin vs. doubling the dose of statin in patients with primary hypercholesterolaemia or mixed dyslipidaemia , 2010, International journal of clinical practice.

[22]  R. Collins,et al.  Efficacy and safety of cholesterol-lowering treatment: prospective meta-analysis of data from 90 056 participants in 14 randomised trials of statins , 2005, The Lancet.

[23]  B. Solow,et al.  The impact of automatic prescriptions on reducing low-density lipoprotein cholesterol levels. , 2000, Effective clinical practice : ECP.

[24]  Lawrence A Leiter,et al.  Use of a treatment optimization algorithm involving statin-ezetimibe combination aids in achievement of guideline-based low-density lipoprotein targets in patients with dyslipidemia at high vascular risk Guideline-based Undertaking to Improve Dyslipidemia Management in Canada (GUIDANC). , 2011, The Canadian journal of cardiology.